Literature DB >> 11293438

Hypofractionation for prostate cancer.

J P Logue, R A Cowan, J H Hendry.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11293438     DOI： 10.1016/s0360-3016(00)01565-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  4 in total

Review 1.  [Optimizing the use of radiotherapy with IMRT and image guided location of advanced prostate cancer].

Authors:  F Lohr; M Fuss; U Tiefenbacher; M Siegsmund; S Mai; J M Kunnappallil; B Dobler; P Alken; F Wenz
Journal:  Urologe A       Date:  2004-01       Impact factor: 0.639

2.  Endo-rectal balloon cavity dosimetry in a phantom: performance under IMRT and helical tomotherapy beams.

Authors:  Nicholas Hardcastle; Peter E Metcalfe; Anatoly B Rosenfeld; Wolfgang A Tomé
Journal:  Radiother Oncol       Date:  2009-03-30       Impact factor: 6.280

3.  Dose-escalated hypofractionated intensity-modulated radiotherapy in high-risk carcinoma of the prostate: outcome and late toxicity.

Authors:  David Thomson; Sophie Merrick; Ric Swindell; Joanna Coote; Kay Kelly; Julie Stratford; James Wylie; Richard Cowan; Tony Elliott; John Logue; Ananya Choudhury; Jacqueline Livsey
Journal:  Prostate Cancer       Date:  2012-06-20

4.  Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a phase I/II feasibility study.

Authors:  Sara Junius; Karin Haustermans; Barbara Bussels; Raymond Oyen; Bianca Vanstraelen; Tom Depuydt; Jan Verstraete; Steven Joniau; Hendrik Van Poppel
Journal:  Radiat Oncol       Date:  2007-08-08       Impact factor: 3.481
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.